Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study.
Ann Transl Med
; 9(16): 1334, 2021 Aug.
Article
de En
| MEDLINE
| ID: mdl-34532471
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Langue:
En
Journal:
Ann Transl Med
Année:
2021
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Chine